Stay updated on Cladribine, Idarubicin & Cytarabine for AML Clinical Trial
Sign up to get notified when there's something new on the Cladribine, Idarubicin & Cytarabine for AML Clinical Trial page.

Latest updates to the Cladribine, Idarubicin & Cytarabine for AML Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov interface as revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check24 days agoChange DetectedA banner announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” and provides a link to updates and FAQs.SummaryDifference0.6%

- Check30 days agoChange DetectedThe site revision label in the footer changed from v3.7.1 to v3.7.2; the study record content remains unchanged.SummaryDifference0.1%

- Check37 days agoChange DetectedThe site footer revision number changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check58 days agoChange DetectedThe Record History shows a new version tag (v3.7.0) and a newly labeled 'Find contact information' link, while the previous capitalized label 'Find Contact Information' and older revision tag (v3.6.6) were removed, indicating a small UI text adjustment and version update.SummaryDifference0.2%

- Check80 days agoChange DetectedNew Revision: v3.6.6 has been added to the page's revision history, replacing the previous v3.6.5. This update represents a metadata/version change to the page rather than alterations to the study content.SummaryDifference0.1%

Stay in the know with updates to Cladribine, Idarubicin & Cytarabine for AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cladribine, Idarubicin & Cytarabine for AML Clinical Trial page.